First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on: January 30,2024

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on:January 30,2024

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on: May 11,2024

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on:May 11,2024

Study identifies new treatment target for metastatic cancer

by Elizabeth Chapin,University of KentuckySuccinate levels are elevated during EMT. (A) Expression of EMT markers was assessed by western blot in control, Snail1- and Twist1-expressing HMLE cell

Updated on: February 18,2024

Study identifies new treatment target for metastatic cancer

by Elizabeth Chapin,University of KentuckySuccinate levels are elevated during EMT. (A) Expression of EMT markers was assessed by western blot in control, Snail1- and Twist1-expressing HMLE cell

Updated on:February 18,2024

New study shows recently diagnosed adult cancer survivors at higher risk for bone fractures

byAmerican Cancer SocietyAdult cancer survivors at increased risk for bone fractures. Credit: American Cancer SocietyAdult cancer survivors, particularly those diagnosed within five years and/or

Updated on: January 12,2024

New study shows recently diagnosed adult cancer survivors at higher risk for bone fractures

byAmerican Cancer SocietyAdult cancer survivors at increased risk for bone fractures. Credit: American Cancer SocietyAdult cancer survivors, particularly those diagnosed within five years and/or

Updated on:January 12,2024

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and

Updated on: February 03,2024

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and

Updated on:February 03,2024

Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

by American Association for Cancer ResearchCancer cell during cell division. Credit: National Institutes of HealthAfrican American breast cancer patients who received second opinions from an NCI-

Updated on: April 01,2024

Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

by American Association for Cancer ResearchCancer cell during cell division. Credit: National Institutes of HealthAfrican American breast cancer patients who received second opinions from an NCI-

Updated on:April 01,2024

Researchers uncover aberrant natural killer cell subtype

by University of Science and Technology of ChinaGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.07.034A team led by Prof. Tian Zhigang and Prof. Peng Hui from the Universit

Updated on: June 15,2024

Researchers uncover aberrant natural killer cell subtype

by University of Science and Technology of ChinaGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.07.034A team led by Prof. Tian Zhigang and Prof. Peng Hui from the Universit

Updated on:June 15,2024

Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainColorectal cancer is a leading cancer-related cause of death in the United States, ranking third in in

Updated on: January 29,2024

Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainColorectal cancer is a leading cancer-related cause of death in the United States, ranking third in in

Updated on:January 29,2024

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w

Updated on: January 29,2024

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w

Updated on:January 29,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on: January 22,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on:January 22,2024

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024